QUTRISI Trademark

Trademark Overview


On Wednesday, December 4, 2024, a trademark application was filed for QUTRISI with the United States Patent and Trademark Office. The USPTO has given the QUTRISI trademark a serial number of 79415284. The federal status of this trademark filing is REGISTERED as of Tuesday, June 10, 2025. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The QUTRISI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy (IgAN); pharmaceutical preparations for treatment of autoimmune diseases and disorders.
qutrisi

General Information


Serial Number79415284
Word MarkQUTRISI
Filing DateWednesday, December 4, 2024
Status700 - REGISTERED
Status DateTuesday, June 10, 2025
Registration Number7821534
Registration DateTuesday, June 10, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 22, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy (IgAN); pharmaceutical preparations for treatment of autoimmune diseases and disorders.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, January 23, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 24, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, January 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 29, 2025APPLICATION FILING RECEIPT MAILED
Saturday, March 8, 2025CORRECTION TRANSACTION RECEIVED FROM IB
Monday, March 24, 2025CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Monday, March 24, 2025CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Monday, March 24, 2025ATTORNEY REVIEW COMPLETED
Monday, March 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 21, 2025ASSIGNED TO EXAMINER
Wednesday, April 16, 2025NOTICE OF PUBLICATION
Tuesday, April 22, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 10, 2025REGISTERED-PRINCIPAL REGISTER
Thursday, July 10, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB